Scholars Central

Conference abstractPublished 23 Jul 2018

FAP in a FAP cell line is activated by TGFβ, as in CAFs of pancreatic cancer

Authors: Dina Antonova, Pleshkan V V, Sverdlov E D

Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry-RAS, Russia

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Pancreatic ductal adenocarcinoma is an extremely aggressive form of cancer with poor prognosis. It is presumably due to a high content of the tumor microenvironment that promotes tumor progression. Cancer-associated fibroblasts (CAFs) are one of the main components of the tumor microenvironment. Fibroblast activation protein (FAP) is a serine protease, specifically expressed in CAFs and considered to be a potential selective target for tumor therapy. Expression of FAP was confirmed by immunofluorescence staining of FAP in primary cultures of pancreatic CAFs. Simultaneous staining of FAP and the cell membrane revealed their co-localization. Apparently, this allows FAP to perform its enzymatic function and to modify the extracellular matrix most efficiently. Previous screening of cell lines identified a FAP-positive non-fibroblast cell line OSA (SJSA-1) which was similar, in terms of FAP expression, to pancreatic CAFs derived from surgical pancreatic tumor samples. Like in primary cultures of pancreatic CAFs, the FAP protein was co-localized with the cell membrane also in the OSA cell line. It is known that TGFÃ?Â?Ã?² is the main regulator of FAP expression in CAFs. We attempted to investigate the effect of TGFÃ?Â?Ã?² on the expression of FAP in the OSA cell line. To this end, the OSA cell line was cultured in depleted medium in the presence of TGFb. In contrast to control cells incubated without TGFÃ?Â?Ã?², we observed an increase in the FAP expression. Thus, TGFÃ?Â?Ã?² upregulated the expression of FAP in a FAP-positive cell line. We assume that the FAP-positive non-fibroblast OSA (SJSA-1) cell line can be efficiently used to study FAP targeting and regulation.This study was supported by the Russian Science Foundation (project no. 14-50-00131). Recent Publications: 1. Tyulkina (Antonova) D V, Pleshkan V V, Alekseenko I V, Kopantseva M R and Sverdlov E D (2016) Expression of the FAP gene in non-fibroblast human cell lines. Development of cancer-associated fibroblast models. Dokl Biochem Biophys. 470(1):319Ã?¢Ã?Â?Ã?Â?321. 2. Pleshkan V V, Alekseenko I V, Tyulkina (Antonova) D V, Kyzmich A I, Zinovyeva M V, et al. (2016) Fibroblast activation protein FAP as a possible target of the antitumor strategy. Molecular Genetics, Microbiology and Virology 34(3):4Ã?¢Ã?Â?Ã?Â?11. 3. Alekseenko I V, Kuzmich A I, Pleshkan V V, Tyulkina (Antonova) D V, Zinovyeva M V, et al. (2016) The cause of cancer mutations: Improvable bad life or inevitable stochastic replication errors? Mol. Biol. 50(6):906Ã?¢Ã?Â?Ã?Â?921. 4. Didych D A, Tyulkina (Antonova) D V, Pleshkan V V, Alekseenko I V and Sverdlov E D (2015) Super-enhancers. Are they regulators of regulatory genes of development and cancer? Mol. Biol. 49(6):915Ã?¢Ã?Â?Ã?Â?22. 5. Kuzmich A I, Tyulkina (Antonova) D V, Vinogradova T V and Sverdlov E D (2015) Pioneer transcription factors in normal development and in carcinogenesis. Bioorg. Khim. 41(6):636Ã?¢Ã?Â?Ã?Â?43.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Cancer Science & Therapy.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalCancer Science & Therapy
  • SubjectOncology & Cancer
  • BylineArticles whose byline prints “Dina Antonova”
  • BylineArticles whose byline prints “Pleshkan V V”
  • BylineArticles whose byline prints “Sverdlov E D”